GlassScriptPhysician profile
Naveed Khan
NPI 1588243174
$1,608.47
in general payments reported to CMS, 2019-2025
10 companies · $512 in 2025
The $512 reported for 2025 was more than what 79% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $146 · 2022: $415 · 2024: $535 · 2025: $512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $950 · Education: $98.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $949.53 |
| Education | $98.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $600.88 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Csl Behring | $248.94 | 2022 | |
| Abbvie INC. | $164.08 | 2024-2025 | |
| Polynovo North America LLC | $161.25 | 2025 | Novosorb Btm |
| Allergan, INC. | $145.91 | 2021 | |
| Kci USA, INC. | $99.17 | 2022 | |
| Medical Device Business Services, INC. | $98.00 | 2024 | |
| Olympus America INC. | $48.29 | 2022 | |
| Smith+Nephew, INC. | $23.32 | 2025 | Renasys Touch, Pico 14 |
| Pacira Pharmaceuticals Incorporated | $18.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naveed Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.